Patterns and trends in insulin initiation and intensification among patients with type 2 diabetes mellitus in the Western Pacific region

References

• International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. Available at: http://www.diabetesatlas.org [Last accessed 2 October 2017]
   Google Scholar
• Lind M, Odén A, Fahlén M, Eliasson B. The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables. PLoS One 2009;4:e4412
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2015;58:429-42
   PubMed Web of Science ®Google Scholar
• Khunti K, Wolden ML, Thorsted BL, et al. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 2013;36:3411-17
   PubMed Web of Science ®Google Scholar
• Asche CV, Bode B, Busk AK, et al. The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes Obes Metab 2012;14:47-57
   PubMed Web of Science ®Google Scholar
• Home P, Haddad J, Latif ZA, et al. Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western countries. Diabetes Ther 2013;4:91-102
   PubMed Web of Science ®Google Scholar
• Home P, Naggar NE, Khamseh M, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract 2011;94:352-63
   PubMed Web of Science ®Google Scholar
• Tsai ST, Pathan F, Ji L, et al. First insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in Asia. J Diabetes 2011;3:208-16
   PubMed Web of Science ®Google Scholar
• Ji L, Tsai ST, Lin J, et al. National variations in comorbidities, glycosylated hemoglobin reduction, and insulin dosage in Asian patients with type 2 diabetes: the FINE-Asia Registry. Diabetes Ther 2015;6:519-30
   PubMed Web of Science ®Google Scholar
• Polinski JM, Kim SC, Jiang D, et al. Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc). BMC Endocr Disord 2015;15:46
   PubMed Web of Science ®Google Scholar
• Hayes RP, Curtis B, Ilag L, et al. Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy. J Diabetes 2013;5:358-67
   PubMed Web of Science ®Google Scholar
• Hayes RP, Naegeli AN. The contribution of pretreatment expectations and expectation–perception difference to change in treatment satisfaction and end point treatment satisfaction in the context of initiation of inhaled insulin therapy in patients with type 2 diabetes. Diabetes Technol Ther 2010;12:447-53
   PubMed Web of Science ®Google Scholar
• van Reenen M, Oppe M. EQ-5D-3L User Guide. Basic information on how to use the Eq-5D-3L instrument. 2015. Available at: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-3L_UserGuide_2015.pdf [Last accessed August 2017]
   Google Scholar
• Jones GR, Barker G, Goodall I, et al. Change of HbA1c reporting to the new SI units. Med J Aust 2011;195:45-6
   PubMed Web of Science ®Google Scholar
• Hong Kong Department of Health. Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings. 2017. Available at: http://www.pco.gov.hk/english/resource/files/RF_DM_full.pdf [Last accessed August 2017]
   Google Scholar
• Diabetes Association of the Republic of China (Taiwan). Executive Summary: Clinical Practice Guidelines for Diabetes Care – 2015. Formos J Endocrinol Metabol 2015;6(Suppl):1-8
   Google Scholar
• Unite for Diabetes Philippines. Philippine Practice Guidelines on the Diagnosis and Management of Diabetes Mellitus. 2014. Available at: http://endo-society.org.ph/v5/wp-content/uploads/2013/06/Diabetes-United-for-Diabetes-Phil.pdf [Last accessed August 2017]
   Google Scholar
• Academy of Medicine of Malaysia. Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus (5th Edition). 2015. Available at: http://www.acadmed.org.my/index.cfm?&menuid=67#Endocrine_Disease [Last accessed August 2017]
   Google Scholar
• Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J Am Stat Assoc 2016. doi:10.1080/01621459.2016.1260466
   Web of Science ®Google Scholar
• Bailey CJ. Under-treatment of type 2 diabetes: causes and outcomes of clinical inertia. Int J Clin Pract 2016;70:988-995
   PubMed Web of Science ®Google Scholar
• Oguz A, Benroubi M, Brismar K, et al. Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. Curr Med Res Opin 2013;29:911-20
   PubMed Web of Science ®Google Scholar
• Liebl A, Jones S, Goday A, et al. Clinical outcomes after insulin initiation in patients with type 2 diabetes: 24-month results from INSTIGATE. Diabetes Ther 2012;3:9
   PubMedGoogle Scholar
• Reach G, Pechtner V, Gentilella R, et al. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab 2017;43:501-11
   PubMed Web of Science ®Google Scholar
• McFarland MS, Knight TN, Brown A, et al. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence. South Med J 2010;103:58-65
   PubMed Web of Science ®Google Scholar
• Bonafede M, Chandran A, DiMario S, et al. Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study. BMJ Open Diabetes Res Care 2016;4:e000189
   PubMed Web of Science ®Google Scholar
• Matsuba I, Sawa T, Kawata T, et al. Cross-national variation in glycemic control and diabetes-related distress among East Asian patients using insulin: results from the MOSAIc study. Diabetes Ther 2016;7:349-60
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M, Siminerio LM. Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006;29:1249-55
   PubMed Web of Science ®Google Scholar
• Salomon JA, Patel A, Neal B, et al. Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes. Med Care 2011;49:962-70
   PubMed Web of Science ®Google Scholar